BioXcel Therapeutics (BTAI) Institutional Ownership

→ “Forget Tesla, this is Elon’s Next Big Thing” (From InvestorPlace) (Ad)

Free BTAI Stock Alerts

$2.71

-0.04 (-1.45%)

(As of 10:09 AM ET)

Compare

Current Institutional Ownership Percentage: 30.68%
Number of Institutional Buyers (last 12 months): 48
Total Institutional Inflows (last 12 months): $78.98M

Number of Institutional Sellers (last 12 months): 25
Total Institutional Outflows (last 12 months): $28.32M

Get BTAI Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioXcel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BTAI Institutional Buying and Selling by Quarter

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

BioXcel Therapeutics Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/11/2024	Vanguard Group Inc.	1,089,463	$3.21M	0.0%	-10.7%	3.586%
3/1/2024	Goldman Sachs Group Inc.	19,200	$57K	0.0%	-85.6%	0.063%
2/26/2024	Virtu Financial LLC	59,514	$176K	0.0%	N/A	0.196%
2/15/2024	Barclays PLC	27,895	$82K	0.0%	+264.4%	0.092%
2/15/2024	Vanguard Group Inc.	1,089,463	$3.21M	0.0%	-10.7%	3.586%
2/14/2024	Pennant Investors LP	83,900	$248K	0.1%	N/A	0.276%
Get the Latest News and Ratings for BTAI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
2/13/2024	Tower Research Capital LLC TRC	13,832	$41K	0.0%	+239.2%	0.046%
2/13/2024	Goldman Sachs Group Inc.	19,200	$57K	0.0%	-85.6%	0.063%
2/9/2024	Cambridge Investment Research Advisors Inc.	38,050	$112K	0.0%	N/A	0.127%
2/7/2024	BNP Paribas Financial Markets	23,424	$69K	0.0%	-69.3%	0.078%
2/6/2024	Charles Schwab Investment Management Inc.	187,510	$553K	0.0%	+37.1%	0.626%
2/6/2024	Apollon Wealth Management LLC	10,537	$31K	0.0%	N/A	0.035%
2/2/2024	Truist Financial Corp	10,879	$32K	0.0%	N/A	0.036%
1/23/2024	DAVENPORT & Co LLC	35,385	$104K	0.0%	-42.5%	0.118%
12/18/2023	Vanguard Group Inc.	1,220,530	$3.09M	0.0%	+8.1%	4.170%
12/6/2023	Citigroup Inc.	24,336	$62K	0.0%	-59.5%	0.083%
12/1/2023	Wellington Management Group LLP	36,954	$93K	0.0%	-96.9%	0.126%
11/16/2023	Creative Planning	21,224	$54K	0.0%	N/A	0.073%
11/15/2023	Legal & General Group Plc	13,380	$34K	0.0%	-27.5%	0.046%
11/15/2023	Adage Capital Partners GP L.L.C.	200,000	$506K	0.0%	-89.8%	0.683%
11/15/2023	Ameriprise Financial Inc.	668,370	$1.69M	0.0%	+91.3%	2.283%
11/13/2023	Northern Trust Corp	225,656	$571K	0.0%	-7.6%	0.771%
11/13/2023	FMR LLC	2,700,727	$6.83M	0.0%	-38.2%	9.227%
11/9/2023	Citigroup Inc.	24,336	$62K	0.0%	-59.5%	0.083%
11/9/2023	UBS Group AG	78,604	$199K	0.0%	-29.1%	0.269%
11/8/2023	Charles Schwab Investment Management Inc.	136,803	$346K	0.0%	-7.7%	0.467%
10/27/2023	Hennion & Walsh Asset Management Inc.	33,940	$86K	0.0%	+89.5%	0.116%
10/24/2023	Bank of New York Mellon Corp	128,022	$324K	0.0%	+13.2%	0.437%
10/12/2023	SeaCrest Wealth Management LLC	16,550	$42K	0.0%	-20.0%	0.057%
8/15/2023	Alliancebernstein L.P.	35,880	$239K	0.0%	+49.5%	0.123%
8/15/2023	Wells Fargo & Company MN	77,381	$515K	0.0%	+62.5%	0.265%
8/15/2023	Knoll Capital Management LLC	30,000	$200K	0.2%	N/A	0.103%
8/15/2023	XTX Topco Ltd	16,509	$110K	0.0%	N/A	0.057%
8/15/2023	Goldman Sachs Group Inc.	144,046	$959K	0.0%	-12.0%	0.494%
8/15/2023	Point72 Asset Management L.P.	241,958	$1.61M	0.0%	N/A	0.830%
8/15/2023	Hudson Bay Capital Management LP	29,300	$195K	0.0%	N/A	0.100%
8/14/2023	Tower Research Capital LLC TRC	5,679	$38K	0.0%	+271.4%	0.019%
8/14/2023	State of Wisconsin Investment Board	28,623	$191K	0.0%	+19.8%	0.098%
8/14/2023	State Street Corp	2,072,199	$13.80M	0.0%	+17.7%	7.106%
8/14/2023	Nuveen Asset Management LLC	14,808	$99K	0.0%	-75.9%	0.051%
“Forget Tesla, this is Elon’s Next Big Thing” (Ad) According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley. Click here to see the details.
8/14/2023	Driehaus Capital Management LLC	22,220	$148K	0.0%	-94.3%	0.076%
8/14/2023	Thrivent Financial for Lutherans	10,000	$64K	0.0%	N/A	0.034%
8/11/2023	Credit Suisse AG	31,456	$209K	0.0%	+75.1%	0.108%
8/11/2023	BlackRock Inc.	1,389,229	$9.25M	0.0%	+1.4%	4.764%
8/11/2023	Geode Capital Management LLC	404,650	$2.70M	0.0%	+5.6%	1.388%
8/11/2023	E Fund Management Co. Ltd.	10,628	$71K	0.0%	N/A	0.036%
8/11/2023	JPMorgan Chase & Co.	21,440	$143K	0.0%	+24.0%	0.074%
8/11/2023	Northern Trust Corp	244,106	$1.63M	0.0%	+15.3%	0.837%
8/10/2023	Profund Advisors LLC	35,475	$236K	0.0%	+29.2%	0.122%
8/10/2023	US Bancorp DE	14,072	$94K	0.0%	+42,542.4%	0.048%
8/10/2023	Charles Schwab Investment Management Inc.	148,174	$987K	0.0%	+3.0%	0.508%
8/10/2023	Citigroup Inc.	60,062	$400K	0.0%	-49.5%	0.206%
8/9/2023	Dimensional Fund Advisors LP	37,668	$251K	0.0%	-38.7%	0.129%
8/9/2023	BNP Paribas Arbitrage SNC	69,994	$466K	0.0%	-38.5%	0.240%
8/9/2023	Swiss National Bank	44,200	$294K	0.0%	+4.5%	0.152%
8/3/2023	Barclays PLC	100,720	$671K	0.0%	+79.8%	0.344%
8/3/2023	Bank of New York Mellon Corp	113,121	$753K	0.0%	+46.7%	0.388%
7/25/2023	Raymond James & Associates	18,648	$124K	0.0%	+32.7%	0.064%
7/20/2023	DAVENPORT & Co LLC	59,705	$398K	0.0%	-25.6%	0.205%
7/19/2023	Artemis Investment Management LLP	895,048	$5.96M	0.1%	-8.8%	3.069%
7/14/2023	SeaCrest Wealth Management LLC	20,700	$138K	0.0%	+38.9%	0.071%
5/18/2023	JPMorgan Chase & Co.	17,291	$322K	0.0%	+49.1%	0.059%
5/18/2023	New York State Common Retirement Fund	10,885	$203K	0.0%	-5.9%	0.037%
5/16/2023	State Street Corp	1,760,683	$32.85M	0.0%	+377.7%	6.038%
5/16/2023	Geode Capital Management LLC	383,129	$7.15M	0.0%	+2.2%	1.314%
5/15/2023	Two Sigma Advisers LP	57,400	$1.07M	0.0%	+95.2%	0.198%
5/15/2023	Two Sigma Investments LP	217,991	$4.07M	0.0%	N/A	0.751%
5/15/2023	Deutsche Bank AG	27,665	$516K	0.0%	+14.5%	0.095%
5/12/2023	Renaissance Technologies LLC	94,000	$1.75M	0.0%	N/A	0.324%
5/12/2023	BlackRock Inc.	1,370,688	$25.58M	0.0%	-6.3%	4.725%
5/12/2023	BNP Paribas Arbitrage SNC	113,770	$2.12M	0.0%	+221.6%	0.392%
5/12/2023	AlphaCentric Advisors LLC	40,000	$746K	0.5%	-20.0%	0.138%
5/12/2023	Bank of America Corp DE	340,925	$6.36M	0.0%	+193.0%	1.175%
5/12/2023	UBS Group AG	160,289	$2.99M	0.0%	+15.1%	0.553%
5/12/2023	Dimensional Fund Advisors LP	61,432	$1.15M	0.0%	-11.4%	0.212%
5/12/2023	Wellington Management Group LLP	1,334,606	$24.90M	0.0%	N/A	4.601%
5/12/2023	SeaCrest Wealth Management LLC	14,907	$278K	0.0%	N/A	0.051%
5/12/2023	Charles Schwab Investment Management Inc.	143,893	$2.69M	0.0%	+0.4%	0.496%
5/12/2023	Profund Advisors LLC	27,462	$512K	0.0%	N/A	0.095%
5/11/2023	FMR LLC	4,276,693	$79.80M	0.0%	+1.7%	14.742%
5/11/2023	Rhumbline Advisers	33,490	$625K	0.0%	+8.5%	0.115%
5/11/2023	Citigroup Inc.	118,975	$2.22M	0.0%	+19,120.5%	0.410%
5/10/2023	Credit Suisse AG	17,963	$335K	0.0%	+28.5%	0.062%
5/10/2023	Tocqueville Asset Management L.P.	37,000	$690K	0.0%	-6.1%	0.128%
5/10/2023	Swiss National Bank	42,300	$789K	0.0%	-8.6%	0.146%
5/9/2023	Tower Research Capital LLC TRC	1,529	$29K	0.0%	+205.2%	0.005%
5/9/2023	Bank of New York Mellon Corp	77,132	$1.44M	0.0%	+7.2%	0.266%
5/8/2023	Federated Hermes Inc.	61,730	$1.15M	0.0%	N/A	0.213%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	12,103	$226K	0.0%	+8.2%	0.042%
5/5/2023	Truist Financial Corp	11,353	$212K	0.0%	-4.9%	0.039%
“Forget Tesla, this is Elon’s Next Big Thing” (Ad) According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley. Click here to see the details.
5/5/2023	Artemis Investment Management LLP	981,472	$18.28M	0.2%	-26.4%	3.383%
5/4/2023	Barclays PLC	56,023	$1.05M	0.0%	+990.8%	0.193%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	14,137	$264K	0.0%	N/A	0.049%
4/27/2023	DAVENPORT & Co LLC	80,295	$1.50M	0.0%	-48.9%	0.277%
4/21/2023	Capital Investment Advisory Services LLC	17,325	$323K	0.0%	N/A	0.060%
4/20/2023	Hennion & Walsh Asset Management Inc.	37,887	$707K	0.0%	-3.3%	0.131%
4/14/2023	Raymond James & Associates	14,052	$262K	0.0%	-11.8%	0.048%
4/13/2023	Allspring Global Investments Holdings LLC	49,311	$920K	0.0%	N/A	0.170%
2/21/2023	Northwestern Mutual Wealth Management Co.	1,740	$37K	0.0%	+411.8%	0.006%
2/17/2023	Truist Financial Corp	11,935	$256K	0.0%	-48.8%	0.043%

(Data available from 1/1/2016 forward)

BTAI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of BTAI shares?: During the previous two years, 93 institutional investors and hedge funds held shares of BioXcel Therapeutics. The most heavily invested institutionals were State Street Corp ($13.80M), BlackRock Inc. ($9.25M), FMR LLC ($6.83M), Bank of America Corp DE ($6.36M), Artemis Investment Management LLP ($5.96M), Massachusetts Financial Services Co. MA ($5.37M), and Two Sigma Investments LP ($4.07M).Learn more on BTAI's institutional investors.
What percentage of BioXcel Therapeutics stock is owned by institutional investors?: 30.68% of BioXcel Therapeutics stock is owned by institutional investors. Learn more on BTAI's institutional investor holdings.
Which institutional investors have been buying BioXcel Therapeutics stock?: Of the 86 institutional investors that purchased BioXcel Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: State Street Corp ($1.76M), Wellington Management Group LLP ($1.34M), Driehaus Capital Management LLC ($505.93K), Ameriprise Financial Inc. ($318.91K), Bank of America Corp DE ($278.94K), Point72 Asset Management L.P. ($241.96K), and Two Sigma Investments LP ($217.99K).

How much institutional buying is happening at BioXcel Therapeutics?: Institutional investors have bought a total of 7,707,126 shares in the last 24 months. This purchase volume represents approximately $118.67M in transactions.
Which BioXcel Therapeutics major shareholders have been selling company stock?: Of the 43 institutional investors that sold BioXcel Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($1.75M), FMR LLC ($1.67M), Wellington Management Group LLP ($1.17M), State Street Corp ($1.04M), Artemis Investment Management LLP ($533.18K), Driehaus Capital Management LLC ($366.55K), and Vanguard Group Inc. ($262.13K).
How much institutional selling is happening at BioXcel Therapeutics?: Institutional investors have sold a total of 8,313,097 shares in the last 24 months. This volume of shares sold represents approximately $54.16M in transactions.

Related Companies:

This page (NASDAQ:BTAI) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

BioXcel Therapeutics (BTAI) Institutional Ownership

BTAI Institutional Buying and Selling by Quarter

BioXcel Therapeutics Major Shareholders & Ownership History

BTAI Institutional Ownership - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BioXcel Therapeutics (BTAI) Institutional Ownership

Institutional Ownership Changes (13F Filings) for BioXcel Therapeutics (NASDAQ:BTAI)

BTAI Institutional Buying and Selling by Quarter

BioXcel Therapeutics Major Shareholders & Ownership History

BTAI Institutional Ownership - Frequently Asked Questions